講演情報
[P1-37]Modulating reactogenicity and immunogenicity in mRNA-LNP vaccines through lipid component optimization
*Haruki Hirata1,2,3, Yoshino Kawaguchi2, Mari Kimura2,4, Hiroki Tanaka1,5, Toshiro Hirai1,2,3,6, Hidetaka Akita1,5, Taro Shimizu1,2,6, Yasuo Yoshioka1,2,3,4,6,7,8 (1. Center for Advanced Modalities and DDS, Osaka University (Japan), 2. Research Institute for Microbial Diseases, Osaka University (Japan), 3. Graduate School of Pharmaceutical Sciences, Osaka University (Japan), 4. The Research Foundation for Microbial Diseases of Osaka University (Japan), 5. Graduate School of Pharmaceutical Sciences, Tohoku University (Japan), 6. Institute for Open and Transdisciplinary Research Initiatives, Osaka University (Japan), 7. Center for Infectious Disease Education and Research, Osaka University (Japan), 8. Global Center for Medical Engineering and Informatics, Osaka University (Japan))
